A. Dix, S. Vlaic, R. Guthke, J. Linde 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012  M. Tvede,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
Cryptococcosis—the impact of delay to diagnosis
J.-C. Lagier  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
J.W.A. Rossen, A.W. Friedrich, J. Moran-Gilad 
I.J. Schalk  Clinical Microbiology and Infection 
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
Changes in the intestinal microbiota from adulthood through to old age
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
B. Barbé, C.P. Yansouni, D. Affolabi, J. Jacobs 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.
Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children  N. Agrinier, M. Le Maréchal,
R. Cantón  Clinical Microbiology and Infection 
Personalized Disease Models on a Chip
Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans?  J.-Y. Madec, M. Haenni, P. Nordmann,
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure  Y.-C. Wang, Y.-T.
Koch's postulates, microbial dysbiosis and inflammatory bowel disease
Non-antibiotic strategies for sepsis
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
The importance of enterovirus surveillance in a Post-polio world
First isolation of Akkermansia muciniphila in a blood-culture sample
Hepatitis C: global epidemiology and strategies for control
Vector control: a cornerstone in the malaria elimination campaign
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts  R. Freeman 
Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions 
Epidemiology of opportunistic infections in AIDS patients
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
Personalized Disease Models on a Chip
Acute schistosomiasis, a diagnostic and therapeutic challenge
New diagnostic tools in schistosomiasis
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
S. David, M. Mentasti, J. Parkhill, V.J. Chalker 
Previously unknown species of Aspergillus
Symposia and Oral Presentations
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Clinical Microbiology and Infection
Statin use and clinical outcomes among pneumonia patients
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study  A. Doi, T.
Virology: a scientific discipline facing new challenges
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
J.L. Balcázar  Clinical Microbiology and Infection 
CMI editorial report, 2016 Clinical Microbiology and Infection
Molecular history of plague
Impact of antibiotic restrictions: the patient's perspective
The burden of chikungunya in the Pacific
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Use of systems biology to decipher host–pathogen interaction networks and predict biomarkers  A. Dix, S. Vlaic, R. Guthke, J. Linde  Clinical Microbiology and Infection  Volume 22, Issue 7, Pages 600-606 (July 2016) DOI: 10.1016/j.cmi.2016.04.014 Copyright © 2016 The Authors Terms and Conditions

Fig. 1 Overview of the relations of systems biology approaches for biomarker discovery, network inference and module discovery. With the help of omics data, biomarkers can be identified that indicate patient conditions and may serve as diagnostic or prognostic marker. Omics data are used for network inference, where, with support of prior knowledge, regulatory networks are reconstructed. These networks predict novel molecular interactions as well as important key regulatory molecules, which may become novel therapeutic targets. The interaction network derived from prior knowledge forms the basis for the discovery of disease modules. Creation of hypotheses in this field is supported by omics data and/or known associations between diseases and molecules. All three approaches require experimental validation of the generated hypotheses, which then serve as new prior knowledge for future experiments and analyses. Clinical Microbiology and Infection 2016 22, 600-606DOI: (10.1016/j.cmi.2016.04.014) Copyright © 2016 The Authors Terms and Conditions